Bowie Christopher R, Harvey Philip D
Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA.
Curr Opin Investig Drugs. 2006 Jul;7(7):608-13.
Cognitive deficits are a core feature of schizophrenia and are a major contributor to functional disability. These impairments persist even when patients are in remission of psychotic symptoms and have, to date, eluded treatment. While some improvement is noted with existing medications, current trends in this field include studying and searching for adjunctive treatments to truly remediate cognitive dysfunction in schizophrenia. Psychosocial treatments have demonstrated some success, but the use of existing cognitive enhancers in schizophrenia treatment has provided little cognitive improvement. This paper reviews the current status of cognitive deficit treatment in schizophrenia and offers suggestions for future work.
认知缺陷是精神分裂症的核心特征,也是导致功能残疾的主要因素。即使患者的精神病症状已缓解,这些损害依然存在,并且迄今为止仍未得到有效治疗。虽然现有药物治疗有一定改善,但该领域目前的趋势是研究并寻找辅助治疗方法,以真正纠正精神分裂症患者的认知功能障碍。心理社会治疗已取得一定成效,但在精神分裂症治疗中使用现有的认知增强剂,对认知功能的改善甚微。本文综述了精神分裂症认知缺陷治疗的现状,并对未来研究方向提出建议。